Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhaoming Li

Showing results (111-120 of 136) with videos related to

Pageof 14
Sort By:
Drug Design, Development and Therapy|March 12, 2020
Apatinib in Patients with Relapsed or Refractory Diffuse Large B Cell Lymphoma: A Phase II, Open-Label, Single-Arm, Prospective StudyXinran Ma, Ling Li, Lei Zhang, et al.
Journal of Cellular Biochemistry|March 3, 2019
c-Myc mediated upregulation of long noncoding RNA SNHG12 regulates proliferation and drug sensitivity in natural killer/T-cell lymphomaLinan Zhu, Xudong Zhang, Xiaorui Fu, et al.
The Oncologist|April 7, 2019
Complete Blood Count Score Model Integrating Reduced Lymphocyte-Monocyte Ratio, Elevated Neutrophil-Lymphocyte Ratio, and Elevated Platelet-Lymphocyte Ratio Predicts Inferior Clinical Outcomes in Adult T-Lymphoblastic LymphomaXiaoyan Feng, Ling Li, Jingjing Wu, et al.
Oncotarget|April 18, 2018
An open label, single-armed, exploratory study of apatinib (a novel VEGFR-2 tyrosine kinase inhibitor) in patients with relapsed or refractory non-Hodgkin lymphomaLing Li, Sa Xiao, Lei Zhang, et al.
Gut|December 9, 2024
Butyrate-producing <i>Faecalibacterium prausnitzii</i> suppresses natural killer/T-cell lymphoma by dampening the JAK-STAT pathwayZhuangzhuang Shi, Min Li, Chen Zhang, et al.
Cancer Cell International|October 11, 2018
Conserved cell populations in doxorubicin-resistant human nasal natural killer/T cell lymphoma cell line: super multidrug resistant cells?Xudong Zhang, Xiaorui Fu, Meng Dong, et al.
Journal of Neuro-Oncology|August 16, 2018
Fotemustine, teniposide and dexamethasone versus high-dose methotrexate plus cytarabine in newly diagnosed primary CNS lymphoma: a randomised phase 2 trialJingjing Wu, Lingling Duan, Lei Zhang, et al.
Oncology Letters|February 13, 2016
Expression and clinical significance of cyclooxygenase-2 and interleukin-32 in primary gastric B-cell lymphomaYingying Cui, Zhenchang Sun, Xin Li, et al.
Therapeutic Advances in Medical Oncology|June 20, 2020
Outcomes of GDPT (gemcitabine, cisplatin, prednisone, thalidomide) <i>versus</i> CHOP in newly diagnosed peripheral T-cell lymphoma patientsYuanyuan Sun, Ling Li, Xin Li, et al.
Hematological Oncology|June 1, 2021
Clinical analysis of patients with primary and secondary extranodal natural killer/T-cell lymphoma of central nervous systemXingying Li, Hui Yu, Xiaorui Fu, et al.
Pageof 14

Showing results (111-120 of 136) with videos related to

Sort By:
Pageof 14
Drug Design, Development and Therapy|March 12, 2020
Apatinib in Patients with Relapsed or Refractory Diffuse Large B Cell Lymphoma: A Phase II, Open-Label, Single-Arm, Prospective StudyXinran Ma, Ling Li, Lei Zhang, et al.
Journal of Cellular Biochemistry|March 3, 2019
c-Myc mediated upregulation of long noncoding RNA SNHG12 regulates proliferation and drug sensitivity in natural killer/T-cell lymphomaLinan Zhu, Xudong Zhang, Xiaorui Fu, et al.
The Oncologist|April 7, 2019
Complete Blood Count Score Model Integrating Reduced Lymphocyte-Monocyte Ratio, Elevated Neutrophil-Lymphocyte Ratio, and Elevated Platelet-Lymphocyte Ratio Predicts Inferior Clinical Outcomes in Adult T-Lymphoblastic LymphomaXiaoyan Feng, Ling Li, Jingjing Wu, et al.
Oncotarget|April 18, 2018
An open label, single-armed, exploratory study of apatinib (a novel VEGFR-2 tyrosine kinase inhibitor) in patients with relapsed or refractory non-Hodgkin lymphomaLing Li, Sa Xiao, Lei Zhang, et al.
Gut|December 9, 2024
Butyrate-producing <i>Faecalibacterium prausnitzii</i> suppresses natural killer/T-cell lymphoma by dampening the JAK-STAT pathwayZhuangzhuang Shi, Min Li, Chen Zhang, et al.
Cancer Cell International|October 11, 2018
Conserved cell populations in doxorubicin-resistant human nasal natural killer/T cell lymphoma cell line: super multidrug resistant cells?Xudong Zhang, Xiaorui Fu, Meng Dong, et al.
Journal of Neuro-Oncology|August 16, 2018
Fotemustine, teniposide and dexamethasone versus high-dose methotrexate plus cytarabine in newly diagnosed primary CNS lymphoma: a randomised phase 2 trialJingjing Wu, Lingling Duan, Lei Zhang, et al.
Oncology Letters|February 13, 2016
Expression and clinical significance of cyclooxygenase-2 and interleukin-32 in primary gastric B-cell lymphomaYingying Cui, Zhenchang Sun, Xin Li, et al.
Therapeutic Advances in Medical Oncology|June 20, 2020
Outcomes of GDPT (gemcitabine, cisplatin, prednisone, thalidomide) <i>versus</i> CHOP in newly diagnosed peripheral T-cell lymphoma patientsYuanyuan Sun, Ling Li, Xin Li, et al.
Hematological Oncology|June 1, 2021
Clinical analysis of patients with primary and secondary extranodal natural killer/T-cell lymphoma of central nervous systemXingying Li, Hui Yu, Xiaorui Fu, et al.
Pageof 14